Skip to main content
Sinopharm Tech Holdings Limited logo

Sinopharm Tech Holdings Limited — Investor Relations & Filings

Ticker · 8156 ISIN · KYG2159V1418 HKEX Wholesale and retail trade
Open in API
Filings indexed 1,471 across all filing types
Latest filing 2023-02-14 Interim / Quarterly Rep…
Country HK Hong Kong
Listing HKEX 8156

About Sinopharm Tech Holdings Limited

http://www.sinopharmtech.com.hk

Sinopharm Tech Holdings Limited is an investment holding company primarily engaged in the big health industry and pharmaceutical supply chain business. The company focuses on the trading and distribution of medical and related products, including Chinese patent medicines and health products, targeting the market in the PRC. It develops its supply chain operations using "Internet Plus" services, leveraging technology to provide value-added services to industry operators and product suppliers. The Group is also integrating AI analytics to enhance its operations within the healthcare sector.

Recent filings

Filing Released Lang Actions
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 31 DECEMBER 2022
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 31 DECEMBER 2022' and contains detailed unaudited condensed consolidated interim financial statements including profit or loss, comprehensive income, financial position, segment information, and notes. It references compliance with HKAS 34 'Interim Financial Reporting' and the GEM Listing Rules, indicating it is a formal interim financial report. The document length is substantial (15,000 characters), and it contains actual financial data and analysis for a six-month period, not just an announcement or summary. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2023
2023-02-14 English
SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE ANNUAL REPORT FOR THE YEAR ENDED 30 JUNE 2022
Regulatory Filings Classification · 95% confidence The document is titled as a "SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE ANNUAL REPORT FOR THE YEAR ENDED 30 JUNE 2022" and references the Annual Report for the year ended 30 June 2022. It provides additional information about the New Share Option Scheme related to that Annual Report. The document is relatively short (2971 characters) and does not contain the full Annual Report or detailed financial statements, but rather supplementary information to the Annual Report. According to the "MENU VS MEAL" rule, since this is a supplemental announcement providing additional information related to the Annual Report and not the full report itself, it should be classified as a Regulatory Filing (RNS) rather than the Annual Report (10-K).
2023-02-10 English
POSITIVE PROFIT ALERT
Regulatory Filings Classification · 95% confidence The document is titled 'POSITIVE PROFIT ALERT' and is an announcement made pursuant to the GEM Listing Rules and Inside Information Provisions. It provides a preliminary profit forecast for the six months ended 31 December 2022 based on unaudited consolidated management accounts. The announcement explicitly states that the final unaudited consolidated results will be announced later and that the current information is a preliminary assessment, not audited or reviewed by auditors. The document is relatively short (4347 characters) and serves as an alert or update on expected financial performance rather than a full interim or quarterly report containing actual financial statements or substantive financial data. Therefore, it is not an Interim/Quarterly Report (IR) but rather a regulatory announcement about expected financial results. This fits the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2023-02-06 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2023
Share Issue/Capital Change Classification · 95% confidence The document is a detailed monthly return report concerning movements in securities, specifically focusing on authorized and issued shares, share options, convertible bonds, and other related capital changes for Sinopharm Tech Holdings Limited. It is addressed to the Hong Kong Exchanges and Clearing Limited and includes confirmations related to securities issuance and compliance with listing rules. The content is regulatory in nature, reporting on share capital and securities movements rather than presenting financial performance, management commentary, or earnings results. It does not contain financial statements or management discussion but rather detailed capital structure updates and confirmations. This aligns with the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues, stock splits, or other capital changes.
2023-02-06 English
DATE OF BOARD MEETING
Report Publication Announcement Classification · 95% confidence The document is an announcement from Sinopharm Tech Holdings Limited regarding the date of a board meeting scheduled to approve the interim results for the six months ended 31 December 2022 and consider dividend payment. The text does not contain the actual interim financial results or detailed financial data but only announces the upcoming board meeting and the intention to approve and publish the interim results. The document length is short (2380 characters), and it serves as a notice rather than the report itself. According to the rules, such announcements about the timing or scheduling of report approval and publication are classified as Report Publication Announcements (RPA).
2023-02-02 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2022
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return concerning movements in securities, including authorized and issued shares, share options, convertible bonds, and confirmations related to securities issued by Sinopharm Tech Holdings Limited. It is addressed to the Hong Kong Exchanges and Clearing Limited and references compliance with the Exchange Listing Rules, specifically Chapter 19B. The document includes detailed tables of share capital movements, share options, convertible bonds, and confirmations by the company secretary. It is a regulatory submission reporting on share capital and securities movements for the month ended 31 December 2022. It is not an annual or interim financial report, earnings release, or management discussion. It is not a proxy statement, voting results, or a governance report. The document is a regulatory filing reporting on share capital and securities movements as required by the stock exchange rules. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2023-01-06 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.